Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[knuts4oe]

seek

Much thanks for bringing up the subject as I have been thinking a great deal lately about what would be a great choice for the first disease target

I wouldn't bet on it, but my choice would be Diabetes 2.

There are currently over 300 million with the disease, and the rate of growth of new cases is increasing. The current sales of D-2 meds is 35 billion with 58 billion forcast for 2018.

Another consideration is that the reported results from the Flint study highlighted the impressive results from subjects taking Metformin. Also believe that at least 2 of the major D-2 drugs are going off patent shortly. At any rate IMO Star/Rock Creek is in an incredible position now.